Solid Biosciences LLC Earnings

The next earnings date for Solid Biosciences LLC has not yet been scheduled.

Analyst Estimates of Solid Biosciences LLC Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Solid Biosciences LLC Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/13/2025	Before Market	---	---
03/11/2025	Before Market	$-1	-27.84%
11/06/2024	After Market	$-0.79	-17.91%
08/13/2024	Before Market	$-0.61	6.15%
05/15/2024	Before Market	$-0.64	0.00%
03/13/2024	Before Market	$-1	-1.01%
11/08/2023	After Market	$-1.05	11.76%
08/14/2023	After Market	$-1.25	18.30%
05/11/2023	Before Market	$-1.50	26.83%
03/23/2023	Before Market	$-0.68	58.79%
11/10/2022	Before Market	$-2.71	-1.50%
08/11/2022	Before Market	$-3.30	-4.76%
04/27/2022	Before Market	$-3.30	-19.57%
03/14/2022	Before Market	$-2.40	17.53%
11/03/2021	Before Market	$-2.40	20.53%
08/16/2021	After Market	$-2.55	9.57%
05/14/2021	Before Market	$-2.85	41.36%
03/15/2021	After Market	$-4.65	8.64%
11/05/2020	Before Market	$-6.60	-27.66%
08/06/2020	Before Market	$-5.85	21.48%
05/07/2020	Before Market	$-7.65	2.30%
03/12/2020	Before Market	$-9.75	-6.67%
11/12/2019	Before Market	$-10.05	-4.15%
08/14/2019	Before Market	$-11.40	3.47%
05/13/2019	After Market	$-12.75	-34.49%
03/13/2019	Before Market	$-9.49	-4.40%
11/13/2018	Before Market	$-8.25	1.79%
08/10/2018	Before Market	$-7.80	-1.96%
05/10/2018	Before Market	$-8.10	-19.12%
03/29/2018	Before Market	$-13.35	-49.16%
10/23/2017	---	$-0.52	---
02/03/2017	---	$-0.14	---

More About Solid Biosciences LLC

Website

https://www.solidbio.com

Country

USA

Full Time Employees

100

Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It also develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the treatment of TNNT2-mediated dilated cardiomyopathy, which is in preclinical phase; SGT-401 for the treatment of BAG3-mediated dilated cardiomyopathy that is in preclinical phase; SGT-701 for treatment of rare inherited disease characterized by mutations in the RBM20 gene, which is in discovery phase; and other drugs for the treatment of cardiac and other diseases. In addition, the company is involved in developing platform technologies, including capsid libraries; genetic regulators, such as promoters, UTRs, and introns; immunomodulation technologies; manufacturing purity; and dual gene expression, a technology for packaging multiple transgenes into one capsid. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc.; and a license agreement with the University of Washington, University of Missouri, University of Florida, and ICS Maugeri S.p.A. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown, Massachusetts.

“Solid Biosciences LLC Earnings” Can Refer to the Solid Biosciences LLC Earnings Date

Some people say “Solid Biosciences LLC earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Solid Biosciences LLC position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Solid Biosciences LLC Stock on the Earnings Date

If you own Solid Biosciences LLC stock (SLDB) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Solid Biosciences LLC might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Solid Biosciences LLC shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Solid Biosciences LLC Earnings

You can contact us any time if you would like to ask questions about Solid Biosciences LLC earnings or anything else related to the stock market.